Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

NCT00059865 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Liver Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: pemetrexed disodium

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]